Trial · NCT00418834
Registered outcomes28
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 28
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percent Change From Baseline in LDL-C at Week 6 | Baseline and Week 6 | |
| Secondary | Percent Change From Baseline in Low Density Lipoprotein Cholesterol (LDL-C) at Week 12 | Baseline and Week 12 | |
| Secondary | Number of Patients Who Achieved Low Density Lipoprotein Cholesterol (LDL-C) <70 mg/dL at Week 6 | Week 6 | |
| Secondary | Number of Patients Who Achieved Low Density Lipoprotein Cholesterol (LDL-C) <70 mg/dL at Week 12 | Week 12 | |
| Secondary | Number of Patients Who Achieved LDL-C <100 mg/dL for Patients Without Atherosclerotic Vascular Disease (AVD) and LDL-C <70 mg/dL for Patients With Atherosclerotic Vascular Disease (AVD) at Week 6 | Week 6 | |
| Secondary | Number of Patients Who Achieved LDL-C<100 mg/dL for Patients Without AVD and LDL-C<70 mg/dL for Patients With AVD at Week 12 | Week 12 | |
| Other | Percent Change From Baseline in High Density Lipoprotein Cholesterol (HDL-C) at Week 6 | Baseline and Week 6 | |
| Other | Percent Change From Baseline in High Density Lipoprotein Cholesterol (HDL-C) at Week 12 | Baseline and Week 12 | |
| Other | Percent Change From Baseline in Non-High Density Lipoprotein Cholesterol (Non-HDL-C) at Week 6 | Baseline and Week 6 | |
| Other | Percent Change From Baseline in Non-High Density Lipoprotein Cholesterol (Non-HDL-C) at Week 12 | Baseine and Week 12 | |
| Other | Percent Change From Baseline in Total Cholesterol (TC) at Week 6 | Baseline and Week 6 | |
| Other | Percent Change From Baseline in Total Cholesterol (TC) at Week 12 | Baseline and Week 12 | |
| Other | Percent Change From Baseline in Triglycerides (TG) at Week 6 | Baseline and Week 6 | |
| Other | Percent Change From Baseline in Triglycerides (TG) at Week 12 | Baseline and Week 12 | |
| Other | Percent Change From Baseline in Apo Lipoprotein B (Apo B) at Week 6 | Baseline and Week 6 | |
| Other | Percent Change From Baseline in Apo Lipoprotein B (Apo B) at Week 12 | Baseline and Week 12 | |
| Other | Percent Change From Baseline in Apo Lipoprotein A-I (Apo A-I) at Week 6 | Baseline and Week 6 | |
| Other | Percent Change From Baseline in Apo Lipoprotein A-I (Apo A-I) at Week 12 | Baseline and Week 12 | |
| Other | Percent Change From Baseline in Total Cholesterol (TC): High Density Lipoprotein Cholesterol (HDL-C) Ratio at Week 6 | Baseline and Week 6 | |
| Other | Percent Change From Baseline in Total Cholesterol (TC):High Density Lipoprotein Cholesterol (HDL-C) Ratio at Week 12 | Baseline and Week 12 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00418834/registered